Сочетание обструктивного апноэ сна и артериальной гипертензии: клинические рекомендации Европейского респираторного общества и Европейского общества по изучению артериальной гипертензии
Аннотация
По материалам: Parati G., Lombardi C., Hedner J. et al. ERS / ESH Task Force Report. Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur. Respir. J. 2013; 41: 5236538. DOI: 10.1183/09031936.00226711.
Список литературы
1. American Academy of Sleep Medicine. International classification of sleep disorders (ICSD-2). 2nd ed. Diagnostic and coding manual. Westchester: American Academy of Sleep Medicine, 2005.
2. Coccagna G., Mantovani M., Brignani F. et al. Continuous recording of the pulmonary and systemic arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull. Physiopathol. Respir. (Nancy) 1972; 8: 1159–1172.
3. Mancia G., De Backer G., Dominiczak A. et al. 2007 Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2007; 25: 1105–1187.
4. Mancia G., Laurent S., Gabiti+Rosei E. et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J. Hypertens. 2009; 27: 2121–2158.
5. Chobanian A.V., Bakris G.L., Black H.R. et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J.A.M.A. 2003; 289: 2560–2572.
6. McNicholas W.T., Bonsigore M.R. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur. Respir. J. 2007; 29: 156–178.
7. Bixler E.O., Vgontzas A.N., Lin H.M. et al. Association of hypertension and sleep-disordered breathing. Arch. Intern. Med. 2000; 160: 2289–2295.
8. Duran J., Esnaola S., Rubio R. et al. Obstructive sleep apneahypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am. J. Respir. Crit. Care Med.2001; 163: 685–689.
9. Hla K.M., Young T.B., Bidwell T. et al. Sleep apnea and hypertension. A population-based study. Ann. Intern. Med. 1994; 120: 382–388.
10. Nieto F.J., Young T.B., Lind B.K. et al. Association of sleepdisordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. J.A.M.A. 2000; 283: 1829–1836.
11. Tanigawa T., Tachibana N., Yamagishi K. et al. Relationship between sleep-disordered breathing and blood pressure levels in community-based samples of Japanese men. Hypertens. Res. 2004; 27: 479–484.
12. Young T., Peppard P., Palta M. et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch. Intern. Med. 1997; 157: 1746–1752.
13. O'Connor G.T., Caffo B., Newman A.B. et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am. J. Respir. Crit. Care Med. 2009; 179: 1159–1164.
14. Peppard P.E., Young T., Palta M. et al. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med.2000; 342: 1378–1384.
15. Cano+Pumarega I., Duran+Cantolla J., Aizpuru F. et al. Obstructive sleep apnea and systemic hypertension: longitudinal study in the general population: the vitoria sleep cohort. Am. J. Respir. Crit. Care Med. 2011; 184: 1299–1304.
16. Goff E.A., O'Driscoll D.M., Simonds A.K. et al. The cardiovascular response to arousal from sleep decreases with age in healthy adults. Sleep 2008; 31: 1009–1017.
17. Grote L., Hedner J., Peter J.H. Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J. Hypertens. 2000; 18: 679–685.
18. Lavie P., Herer P., Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. Br. Med. J. 2000; 320: 479–482.
19. Davies C.W., Crosby J.H., Mullins R.L. et al. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 2000; 55: 736–740.
20. Hoffstein V. Is snoring dangerous to your health? Sleep 1996; 19: 506–516.
21. Hu F.B., Willett W.C., Colditz G.A. et al. Prospective study of snoring and risk of hypertension in females. Am. J. Epidemiol. 1999; 150: 806–816.
22. Lindberg E., Janson C., Gislason T. et al. Snoring and hypertension: a 10 year follow-up. Eur. Respir. J. 1998; 11: 884–889.
23. Lugaresi E., Cirignotta F., Coccagna G. et al. Some epidemiological data on snoring and cardiocirculatory disturbances. Sleep 1980; 3: 221–224.
24. Olson L.G., King M.T., Hensley M.J. et al. A community study of snoring and sleep-disordered breathing. Health outomes. Am. J. Respir. Crit. Care Med. 1995; 152: 717–720.
25. Waller P.C., Bhopal R.S. Is snoring a cause of vascular disease? An epidemiological review. Lancet 1989; 1: 143–146.
26. Calhoun D.A. Obstructive sleep apnea and hypertension. Curr. Hypertens. Respir. 2010; 12: 189–195.
27. Kapa S., Sert Kuniyoshi F.H., Somers V.K. Sleep apnea and hypertension: interactions and implications for management. Hypertension 2008; 51: 605–608.
28. Kohli P., Balachandran J.S., Malhotra A. Obstructive sleep apnea and the risk for cardiovascular disease. Curr. Atheroscler. Rep. 2011; 13: 138–146.
29. Haas D.C., Foster G.L., Nieto F.J. et al. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic / diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 2005; 111: 614–621.
30. Kwok K.L., Ng D.K., Cheung Y.F. BP and arterial distensibility in children with primary snoring. Chest 2003; 123: 1561–1566.
31. Ng D.K., Chan C.H., Kwok K.L. et al. Childhood obstructive sleep apnoea: hypertension was not mentioned. Br. Med. J. 2005; 331: 405.
32. Zintzaras E., Kaditis A.G. Sleep-disordered breathing and blood pressure in children: a meta-analysis. Arch. Pediatr. Adolesc. Med. 2007; 161: 172–178.
33. Bourjeily G., Ankner G., Mohsenin V. Sleep-disordered breathing in pregnancy. Clin. Chest Med. 2011; 32: 175–189.
34. Izci+Balserak B., Pien G.W. Sleep-disordered breathing and pregnancy: potential mechanisms and evidence for maternal and fetal morbidity. Curr. Opin. Pulm. Med. 2010; 16: 574–582.
35. Bourjeily G., Raker C.A., Chalhoub M. et al. Pregnancy and fetal outcomes of symptoms of sleep-disordered breathing. Eur. Respir. J. 2010; 36: 849–855.
36. Olivarez S.A., Ferres M., Antony K. et al. Obstructive sleep apnea screening in pregnancy, perinatal outcomes, and impact of maternal obesity. Am. J. Perinatol. 2011; 28: 651–658.
37. Blyton D.M., Sullivan C.E., Edwards N. Reduced nocturnal cardiac output associated with preeclampsia is minimized with the use of nocturnal nasal CPAP. Sleep 2004; 27: 79–84.
38. Edwards N., Blyton D.M., Kirjavainen T. et al. Nasal continuous positive airway pressure reduces sleep-induced blood pressure increments in pre-eclampsia. Am. J. Respir. Crit. Care Med.2000; 162: 252–257.
39. Charkoudian N., Rabbitts J.A. Sympathetic neural mechanisms in human cardiovascular health and disease. Mayo Clin. Proc. 2009; 84: 822–830.
40. Parati G., Di Rienzo M., Bonsignore M.R. et al. Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J. Hypertens. 1997; 15: 1621–1626.
41. Noda A., Nakata S., Koike Y. et al. Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens. Res. 2007; 30: 669–76.
42. Lombardi C., Parati G., Cortelli P. et al. Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders. J. Sleep. Res. 2008; 17: 263–270.
43. Ziegler M.G., Milic M., Sun P. Antihypertensive therapy for patients with obstructive sleep apnea. Curr. Opin. Nephrol. Hypertens. 2011; 20: 50–55.
44. Dudenbostel T., Calhoun D.A. Resistant hypertension, obstructive sleep apnoea and aldosterone. J. Hum. Hypertens. 2011; 26: 281–287.
45. Gaddam K., Pimenta E., Thomas S.J. et al. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J. Hum. Hypertens. 2010; 24: 532–537.
46. Pratt+Ubunama M.N., Nishizaka M.K., Boedefeld R.L. et al. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007; 131: 453–459.
47. Drager L.F., Polotsky V.Y., Lorenzi+Filho G. Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest 2011; 140: 534–542.
48. Robinson G.V., Pepperell J.C., Segal H.C. et al. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 2004; 59: 777–782.
49. Steiner S., Jax T., Evers S. et al. Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology 2005; 104: 92–96.
50. Rasche K., Keller T., Tautz B. et al. Obstructive sleep apnea and type 2 diabetes. Eur. J. Med. Res. 2010; 15 (Suppl. 2): 152–156.
51. Basoglu O.K., Sarac F., Sarac S. et al. Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann. Thorac. Med. 2011; 6: 120–125.
52. Zirlik S., Hauck T., Fuchs F.S. et al. Leptin, obestatin and apelin levels in patients with obstructive sleep apnoea syndrome. Med. Sci. Monit. 2011; 17: CR159–CR164.
53. Cowley A.W. Jr. The genetic dissection of essential hypertension. Nature Rev. Genet. 2006; 7: 829–840.
54. Munroe P.B., Wallace C., Xue M.Z. et al. Increased support for linkage of a novel locus on chromosome 5q13 for essential hypertension in the British Genetics of Hypertension Study. Hypertension 2006; 48: 105–111.
55. Riha R.L., Diefenbach K., Jennum P. et al. Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnoea-hypopnoea syndrome. Sleep Med. Rev. 2008; 12: 49–63.
56. Marshall N.S., Wong K.K., Liu P.Y. et al. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008; 31: 1079–1085.
57. Young T., Finn L., Peppard P.E. et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008; 31: 1071–1078.
58. Pack A.I., Platt A.B., Pien G.W. Does untreated obstructive sleep apnea lead to death? A commentary on Young et al. Sleep 2008; 31: 1071–1078 and Marshall et al. Sleep 2008; 31: 1079–1085. Sleep 2008; 31: 1067–1068.
59. Selim B., Won C., Yaggi H.K. Cardiovascular consequences of sleep apnea. Clin. Chest Med.2010; 31: 203–220.
60. Yaggi H.K., Concato J., Kernan W.N. et al. Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med. 2005; 353: 2034–2041.
61. Gottlieb D.J., Yenokyan G., Newman A.B. et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 2010; 122: 352–360.
62. Selim B., Won C., Yaggi H.K. Cardiovascular consequences of sleep apnea. Clin. Chest Med. 2010; 31: 203–220.
63. Peker Y., Hedner J., Norum J. et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am. J. Respir. Crit. Care Med. 2002; 166: 159–165.
64. Redline S., Yenokyan G., Gottlieb D.J. et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am. J. Respir. Crit. Care Med. 2010; 182: 269–277.
65. Shahar E., Whitney C.W., Redline S. et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am. J. Respir. Crit. Care Med. 2001; 163: 19–25.
66. Capampangan D.J., Wellik K.E., Parish J.M. et al. Is obstructive sleep apnea an independent risk factor for stroke? A critically appraised topic. Neurologist 2010; 16: 269–273.
67. Somers V.K., White D.P., Amin R. et al. Sleep apnea and cardiovascular disease: an American Heart Association / American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J. Am. Coll. Cardiol. 2008; 52: 686–717.
68. Doonan R.J., Scheffler P., Lalli M. et al. Increased arterial stiffness in obstructive sleep apnea: a systematic review. Hypertens. Res. 2011; 34: 23–32.
69. Drager L.F., Bortolotto L.A., Figueiredo A.C. et al. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest 2007; 131: 1379–1386.
70. Otto M.E., Belohlavek M., Romero+Corral A. et al. Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am. J. Cardiol. 2007; 99: 1298–1302.
71. Tavil Y., Kanbay A., Sen N. et al. Comparison of right ventricular functions by tissue Doppler imaging in patients with obstructive sleep apnea syndrome with or without hypertension. Int. J. Cardiovasc. Imag. 2007; 23: 469–477.
72. Garrigue S., Pepin J.L., Defaye P. et al. High prevalence of sleep apnea syndrome in patients with long-term pacing: the European Multicenter Polysomnographic Study. Circulation 2007; 115: 1703–1709.
73. Dursunoglu N., Dursunoglu D., Ozkurt S. et al. Effects of CPAP on left ventricular structure and myocardial performance index in male patients with obstructive sleep apnoea. Sleep Med. 2007; 8: 51–59.
74. Shivalkar B., Van de Heyning C., Kerremans M. et al. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J. Am. Coll. Cardiol. 2006; 47: 1433–1439.
75. Witkowski A., Prejbisz A., Florczak E. et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 2011; 58: 559–565.
76. Sim J.J., Rasgon S.A., Derose S.F. Review article: Managing sleep apnoea in kidney diseases. Nephrology (Carlton) 2010; 15: 146–152.
77. Agrawal V., Vanhecke T.E., Rai B. et al. Albuminuria and renal function in obese adults evaluated for obstructive sleep apnea. Nephron. Clin. Pract. 2009; 113: 140–147.
78. Stein J.D., Kim D.S., Mundy K.M. et al. The Association between glaucomatous and other causes of optic neuropathy and sleep apnea. Am. J. Ophthalmol. 2011; 152: 898–998.
79. McNab A.A. The eye and sleep apnea. Sleep Med. Rev. 2007; 11: 269–276.
80. Yumino D., Bradley T.D. Central sleep apnea and CheyneStokes respiration. Proc. Am. Thorac. Soc. 2008; 5: 226–236.
81. Su M.C., Chiu K.L., Ruttanaumpawan P. et al. Lower body positive pressure increases upper airway collapsibility in healthy subjects. Respir. Physiol. Neurobiol. 2008; 161: 306–312.
82. Sin D.D., Fitzgerald F., Parker J.D. et al. Risk factors for central and obstructive sleep apnea in 450 men and females with congestive heart failure. Am. J. Respir. Crit. Care Med.1999; 160: 1101–1106.
83. Kasai T., Bradley T.D. Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications. J. Am. Coll. Cardiol. 2011; 57: 119–127.
84. Bassetti C., Aldrich M.S. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep 1999; 22: 217–223.
85. Bassetti C., Aldrich M.S., Chervin R.D. et al. Sleep apnea in patients with transient ischemic attack and stroke: a prospective study of 59 patients. Neurology 1996; 47: 1167–1173.
86. Iranzo A., Santamaria J., Berenguer J. et al. Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology 2002; 58: 911–916.
87. Parra O., Arboix A., Bechich S. et al. Time course of sleeprelated breathing disorders in first-ever stroke or transient ischemic attack. Am. J. Respir. Crit. Care Med. 2000; 161: 375–380.
88. Bassetti C.L., Milanova M., Gugger M. Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke 2006; 37: 967–972.
89. Harbison J., Ford G.A., James O.F. et al. Sleep-disordered breathing following acute stroke. Quart.J.Med. 2002; 95: 741–747.
90. Hui D.S., Choy D.K., Wong L.K. et al. Prevalence of sleepdisordered breathing and continuous positive airway pressure compliance: results in Chinese patients with first-ever ischemic stroke. Chest 2002; 122: 852–860.
91. Selic C., Siccoli M.M., Hermann D.M. et al. Blood pressure evolution after acute ischemic stroke in patients with and without sleep apnea. Stroke 2005; 36: 2614–2618.
92. Kaneko Y., Hajek V.E., Zivanovic V. et al. Relationship of sleep apnea to functional capacity and length of hospitalization following stroke. Sleep 2003; 26: 293–297.
93. Dyken M.E., Somers V.K., Yamada T. et al. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 1996; 27: 401–407.
94. Parra O., Arboix A., Montserrat J.M. et al. Sleep-related breathing disorders: impact on mortality of cerebrovascular disease. Eur. Respir. J. 2004; 24: 267–272.
95. Turkington P.M., Bamford J., Wanklyn P. et al. Effect of upper airway obstruction on blood pressure variability after stroke. Clin. Sci. (Lond) 2004; 107: 75–79.
96. Good D.C., Henkle J.Q., Gelber D. et al. Sleep-disordered breathing and poor functional outcome after stroke. Stroke 1996; 27: 252–259.
97. Iber C. The AASM manual for the scoring of sleep and associated events: rules, terminology, and technical specifications. Westchester: American Academy of Sleep Medicine, 2007.
98. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667–689.
99. Johns M.W. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest 1993; 103: 30–36.
100. Netzer N.C., Stoohs R.A., Netzer C.M. et al. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann. Intern. Med. 1999; 131: 485–491.
101. Abrishami A., Khajehdehi A., Chung F. A systematic review of screening questionnaires for obstructive sleep apnea. Can. J. Anaesth. 2010; 57: 423–438.
102. Lavie P., Hoffstein V. Sleep apnea syndrome: a possible contributing factor to resistant. Sleep 2001; 24: 721–725.
103. Logan A.G., Perlikowski S.M., Mente A. et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J. Hypertens. 2001; 19: 2271–2277.
104. Logan A.G., Tkacova R., Perlikowski S.M. et al. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur. Respir. J. 2003; 21: 241–247.
105. Marrone O., Romano S., Insalaco G. et al. Influence of sampling interval on the evaluation of nocturnal blood pressure in subjects with and without obstructive sleep apnoea. Eur. Respir. J. 2000; 16: 653–658.
106. Baguet J.P., Hammer L., Levy P. et al. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J. Hypertens. 2005; 23: 521–527.
107. Parati G., Stergiou G.S., Asmar R. et al. European Society of Hypertension practice guidelines for home blood pressure monitoring. J. Hum. Hypertens. 2010; 24: 779–785.
108. Parati G., Pickering T.G. Home blood-pressure monitoring: US and European consensus. Lancet 2009; 373: 876–878.
109. Parati G., Omboni S., Bilo G. Why is out-of-office blood pressure measurement needed? Home blood pressure measurements will increasingly replace ambulatory blood pressure monitoring in the diagnosis and management of hypertension. Hypertension 2009 [in press DOI: 10.1161/?HYPERTENSIONAHA.108.122853].
110. Wolf J., Hering D., Narkiewicz K. Non-dipping pattern of hypertension and obstructive sleep apnea syndrome. Hypertens. Res. 2010; 33: 867–871.
111. Lavie+Nevo K., Pillar G. Evening-morning differences in blood pressure in sleep apnea syndrome: effect of gender. Am J. Hypertens. 2006; 19: 1064–1069.
112. Grote L., Hedner J., Peter J.H. Mean blood pressure, pulse pressure and grade of hypertension in untreated hypertensive patients with sleep-related breathing disorder. J. Hypertens. 2001; 19: 683–690.
113. Pitson D.J., Stradling J.R. Value of beat-to-beat blood pressure changes, detected by pulse transit time, in the management of the obstructive sleep apnoea / hypopnea syndrome. Eur. Respir. J. 1998; 12: 685–692.
114. Peppard P.E., Young T., Palta M. et al. Longitudinal study of moderate weight change and sleep-disordered breathing. J.A.M.A. 2000; 284: 3015–3021.
115. Johansson K., Hemmingsson E., Harlid R. et al. Longer term effects of very low energy diet on obstructive sleep apnoea in cohort derived from randomised controlled trial: prospective observational follow-up study. Br. Med. J. 2011; 342: d3017.
116. Pannain S., Mokhlesi B. Bariatric surgery and its impact on sleep architecture, sleep-disordered breathing, and metabolism. Best Pract. Res. Clin. Endocrinol. Metab. 2010; 24: 745–761.
117. Yee B.J., Phillips C.L., Banerjee D. et al. The effect of sibutramineassisted weight loss in men with obstructive sleep apnoea. Int. J. Obes. (Lond) 2007; 31: 161–168.
118. Grunstein R.R., Stenlof K., Hedner J.A. et al. Two year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity. Sleep 2007; 30: 703–710.
119. Peppard P.E., Young T. Exercise and sleep-disordered breathing: an association independent of body habitus. Sleep 2004; 27: 480–484.
120. Giebelhaus V., Strohl K.P., Lormes W. et al. Physical exercise as an adjunct therapy in sleep apnea-an open trial. Sleep Breath 2000; 4: 173–176.
121. Grote L., Wutkewicz K., Knaack L. et al. Association between blood pressure reduction with antihypertensive treatment and sleep apnea activity. Am. J. Hypertens. 2000; 13: 1280–1287.
122. Kapur V.K., Resnick H.E., Gottlieb D.J. Sleep disordered breathing and hypertension: does self-reported sleepiness modify the association? Sleep 2008; 31: 1127–1132.
123. Barbe F., Duran+Cantolla J., Capote F. et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am. J. Respir. Crit. Care Med. 2010; 181: 718–726.
124. Parati G., Lombardi C. Control of hypertension in nonsleepy patients with obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 2010; 181: 650–652.
125. Bazzano L.A., Khan Z., Reynolds K. et al. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007; 50: 417–423.
126. Alajmi M., Mulgrew A.T., Fox J. et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a metaanalysis of randomized controlled trials. Lung 2007; 185: 67–72.
127. Mo L., He Q.Y. [Effect of long-term continuous positive airway pressure ventilation on blood pressure in patients with obstructive sleep apnea hypopnea syndrome: a metaanalysis of clinical trials]. Zhonghua Yi Xue Za Zhi 2007; 87: 1177–1180.
128. Haentjens P., Van Meerhaeghe A., Moscariello A. et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch. Intern. Med. 2007; 167: 757–764.
129. Andren A., Sjoquist M., Tegelberg A. Effects on blood pressure after treatment of obstructive sleep apnoea with a mandibular advancement appliance – a three-year follow-up. J. Oral Rehabil. 2009; 36: 719–725.
130. Coruzzi P., Gualerzi M., Bernkopf E. et al. Autonomic cardiac modulation in obstructive sleep apnea: effect of an oral jawpositioning appliance. Chest 2006; 130: 1362–1368.
131. Lam B., Sam K., Lam J.C. et al. The efficacy of oral appliances in the treatment of severe obstructive sleep apnea. Sleep Breath 2011; 15: 195–201.
132. Javaheri S., Caref E.B., Chen E. et al. Sleep apnea testing and outcomes in a large cohort of Medicare beneficiaries with newly diagnosed heart failure. Am. J. Respir. Crit. Care Med. 2011; 183: 539–546.
133. Arzt M., Floras J.S., Logan A.G. et al. Suppression of central sleep apnea by continuous positive airway pressure and transplantfree survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007; 115: 3173–3180.
134. Arzt M., Schulz M., Schroll S. et al. Time course of continuous positive airway pressure effects on central sleep apnoea in patients with chronic heart failure. J. Sleep Res. 2009; 18: 20–25.
135. Bradley T.D., Logan A.G., Kimoff R.J. et al. Continuous positive airway pressure for central sleep apnea and heart failure. N. Engl. J. Med. 2005; 353: 2025–2033.
136. McKelvie R.S., Moe G.W., Cheung A. et al. The 2011 Canadian Cardiovascular Society heart failuremanagement guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can. J. Cardiol. 2011; 27: 319–338.
137. Sandberg O., Franklin K.A., Bucht G. et al. Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. Eur. Respir. J. 2001; 18: 630–634.
138. Wessendorf T.E., Wang Y.M., Thilmann A.F. et al. Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke. Eur. Respir. J. 2001; 18: 623–629.
139. Brown D.L., Chervin R.D., Hickenbottom S.L. et al. Screening for obstructive sleep apnea in stroke patients: a cost-effectiveness analysis. Stroke 2005; 36: 1291–1293.
140. Marin J.M., Carrizo S.J., Vicente E. et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046–1053.
141. Martinez+Garcia M.A., Galiano+Blancart R., Roman+San+chez P. et al. Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest 2005; 128: 2123–2129.
142. Hsu C.Y., Vennelle M., Li H.Y. et al. Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure. J. Neurol. Neurosurg. Psychiatry 2006; 77: 1143–1149.
143. Teschler H., Dohring J., Wang Y.M. et al. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am. J. Respir. Crit. Care Med.2001; 164: 614–619.
Для цитирования:
Сочетание обструктивного апноэ сна и артериальной гипертензии: клинические рекомендации Европейского респираторного общества и Европейского общества по изучению артериальной гипертензии. Пульмонология. 2013;(2):11-25.
For citation:
. Co-morbidity of obstructive apnoea and hypertension: clinical recommendations of ERS and ECH. PULMONOLOGIYA. 2013;(2):11-25. (In Russ.)
Просмотров: 327
Послать статью по эл. почте 